A New Era for Drug Safety: DiPharma Francis Publishes Groundbreaking Nitrosamine Detection Study

The Shifting Tides: Is Animal Testing Nearing Its End?

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

Amycretin: Is Novo Nordisk's Oral Wonder Drug the Future of Weight Loss and Diabetes Treatment?

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Tonix Pharmaceuticals Gets the Go-Ahead: TNX-102 Enters Clinical Development for Major Depression

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

The Evolving Landscape of Biotech Innovation and Investment

A Glimmer of Hope? Telo Genomics Stock Jumps as Early Study Shows Leukemia Cell Death

The FDA's Golden Ticket: A Moral Maze in Drug Development

The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery

The High-Stakes Gamble: Summit's Vision vs. Akeso's Strategic Play with Ivonesimab

The Rollercoaster Ride of Hope and Dilution: Galmed's Cancer Breakthrough Sends Stock Soaring—But What About the Small Guys?

The Fibromyalgia Frontier: Why Tonix Pharmaceuticals Just Rocketed into the Spotlight

The Tiny Revolution: How IIT-BHU's Nanomedicine Could Transform Life with Inflammatory Illnesses

The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny

AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis

The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients

The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment

The Small Wonders: How Tabletop Accelerators Are Quietly Reshaping Our World

The Shifting Sands of Science: AbbVie Steps Back from Calico's Longevity Quest

A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative

The Siren Song of Scale: Why Big Pharma's Mega-Mergers So Often Fall Flat

Dragon's Roar in the Lab: How China's Biotech Ambitions Are Quietly Reshaping Global Pharma

A Quiet Revolution? Roche's New MS Drug Offers a Glimmer of Genuine Hope

A Glimmer of Hope: Investigating a Dual-Impact Drug for Parkinsonian Syndromes

The Bidding Blitz: Why Novo Nordisk's Loss to Pfizer Isn't Just About Money

AstraZeneca's Quiet Triumph: A Deeper Dive into Q3's Surprising Win

The Billion-Dollar Battle for a Breakthrough: Pfizer's Big Bet on Oral Obesity Drugs

The Race for a Breakthrough: Pfizer's Bold Bet on Battling Obesity, Outmaneuvering Novo Nordisk

The Weight of Ambition: Pfizer’s Bold Move into the Obesity Race

The Prize Fight for Progress: Pfizer Snags Metacrine in a High-Stakes Metabolic Drug Scramble

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars

The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great GLP-1 Gold Rush: Pfizer Jumps into the Billion-Dollar Battle for Weight Loss Dominance

The Great Weigh-In: Pfizer's Bold Bet in the Billion-Dollar Battle for Obesity Drug Dominance